2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-9-methyl-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4761486

PubChem CID: 162660404

Max Phase: Preclinical

Molecular Formula: C24H27N7O2

Molecular Weight: 445.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1ccc(C)cc1NC(=O)N2

Standard InChI:  InChI=1S/C24H27N7O2/c1-15-4-6-17-19(12-15)27-24(32)28-20-14-25-23(29-22(17)20)26-18-7-5-16(13-21(18)33-3)31-10-8-30(2)9-11-31/h4-7,12-14H,8-11H2,1-3H3,(H,25,26,29)(H2,27,28,32)

Standard InChI Key:  KNHMRRFNHCTVGR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   25.9712   -1.7458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.9701   -2.5653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6781   -2.9743    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6763   -1.3369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3880   -2.5662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3850   -1.7422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0300   -1.2202    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8378   -1.3954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1992   -2.1389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8470   -2.8892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0419   -3.0770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8034   -3.8666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3691   -4.4692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1764   -4.2768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4111   -3.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3427   -0.7528    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.2621   -2.9734    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.2614   -3.7905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5533   -4.1970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5523   -5.0135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2602   -5.4234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9706   -5.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9681   -4.1959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8463   -3.7871    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.1379   -4.1944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2606   -6.2406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.5505   -6.6463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5490   -7.4600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2551   -7.8720    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.9644   -7.4643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9676   -6.6445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2524   -8.6892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7381   -4.8704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 19 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
 14 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4761486

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.53Molecular Weight (Monoisotopic): 445.2226AlogP: 3.91#Rotatable Bonds: 4
Polar Surface Area: 94.65Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.72CX Basic pKa: 7.84CX LogP: 3.68CX LogD: 3.11
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.26

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source